Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2017 Nov 14;69(12):1780–1788. doi: 10.1002/acr.23201

Figure 2. Use of anti-malarials, steroids, immunosuppressants, and major immunosuppressants in ILE patients and SLE patients.

Figure 2

Medical records were reviewed for use of hydroxychloroquine (HCQ), steroids, immunosuppressants (IS; methotrexate, azathioprine, and sulfasalazine), and major IS (mycophenolate mofetil, cyclophosphamide). ILE and SLE patients were compared for the types (A) and numbers (B) of medications used. *P=0.034, ****P<0.0001.